Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 2/2020

27.11.2019 | Image of the Month

Striking neurologic 18F-FDG PET/CT pattern in Devic’s disease (neuromyelitis optica spectrum disorder)

verfasst von: Diego Alfonso López-Mora, Albert Flotats, Alejandro Fernández, Marina Sizova, Valle Camacho, Ignasi Carrió

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

A 59-year-old woman presented conscious, behavioral, and cognitive function disturbance, preceded by 10 days history of fever, vomiting, and tremors. Seizures were ruled out by electroencephalogram. Cerebrospinal fluid (CSF) showed marked inflammatory component, predominantly lymphocytic with some eosinophils, and scarce polymorphonuclear leukocytes. Because of inconclusive clinical features and CSF, an auto-antibodies testing was conducted, which detected auto-antibodies against Aquaporin 4 (AQP4-IgG), a disease-specific serum IgG antibody in patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) [1]. After 2 weeks of progressive neurological deterioration that produced unconsciousness, the patient underwent a whole body 18F-FDG PET/CT. The scan showed expansive and diffuse marked hypermetabolism in the spinal cord [2] (MIP (a) and sagittal slice (b)), as well as intense bilaterally hypermetabolism in optic nerves (axial slice (c); arrow). In contrast, brain MRI was reported as suggestive of meningoencephalitis, with no significant morphological changes in the optic nerves (d). 18F-FDG PET/CT scan highlights the intense central nervous system hypermetabolic pattern in the in acute stages of NMOSD [3], as the core neuropathological process takes place in the spinal cord (myelitis affecting ≥ 3 vertebral segments) and optic nerves (optic neuritis) [4], with alterations of glucose metabolism at such level, even before structural changes become clearly apparent. 18F-FDG PET/CT can be a surrogate marker of the cellular inflammation in NMOSD, as the pathogenesis in the acute stage of the disease is primarily manifested with astrocyte injury and secondary demyelination [5].
Literatur
1.
Zurück zum Zitat Lana-Peixoto MA, Talim N. Neuromyelitis optica spectrum disorder and anti-MOG syndromes. Biomedicines. 2019;7(2).CrossRef Lana-Peixoto MA, Talim N. Neuromyelitis optica spectrum disorder and anti-MOG syndromes. Biomedicines. 2019;7(2).CrossRef
2.
Zurück zum Zitat Kawai M, Shimizu F, Omoto M, Ogasawara J-I, Takahashi T, et al. Neuromyelitis optica shows hypermetabolism in 18- fluorodeoxyglucose positron emission tomography. Clin Exp Neuroimmunol. 2012;3(2):85–7.CrossRef Kawai M, Shimizu F, Omoto M, Ogasawara J-I, Takahashi T, et al. Neuromyelitis optica shows hypermetabolism in 18- fluorodeoxyglucose positron emission tomography. Clin Exp Neuroimmunol. 2012;3(2):85–7.CrossRef
3.
Zurück zum Zitat Higashiyama A, Komori T, Inada Y, Nishizawa M, Nakajima H, et al. Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder. Eur J Nucl Med Mol Imaging. 2017;44(9):1609–10.CrossRef Higashiyama A, Komori T, Inada Y, Nishizawa M, Nakajima H, et al. Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder. Eur J Nucl Med Mol Imaging. 2017;44(9):1609–10.CrossRef
4.
Zurück zum Zitat Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRef Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRef
5.
Zurück zum Zitat Patterson SL, Goglin SE. Neuromyelitis Optica. Rheum Dis Clin N Am. 2017;43(4):579–91.CrossRef Patterson SL, Goglin SE. Neuromyelitis Optica. Rheum Dis Clin N Am. 2017;43(4):579–91.CrossRef
Metadaten
Titel
Striking neurologic 18F-FDG PET/CT pattern in Devic’s disease (neuromyelitis optica spectrum disorder)
verfasst von
Diego Alfonso López-Mora
Albert Flotats
Alejandro Fernández
Marina Sizova
Valle Camacho
Ignasi Carrió
Publikationsdatum
27.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04549-4

Weitere Artikel der Ausgabe 2/2020

European Journal of Nuclear Medicine and Molecular Imaging 2/2020 Zur Ausgabe